| Title: |
World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies to Control Antimicrobial Resistance From Food Animal Production |
| Authors: |
Collignon, Peter C.; Conly, John M.; Andremont, Antoine; McEwen, Scott A.; Aidara-Kane, Awa; for the World Health Organization Advisory Group, BogotáMeeting on Integrated Surveillance of Antimicrobial Resistance (WHO-AGISAR); Agerso, Yvonne; Collignon, Peter; Conly, John; Dang Ninh, Tran; Donado-Godoy, Pilar; Fedorka-Cray, Paula; Fernandez, Heriberto; Galas, Marcelo; Irwin, Rebecca; Karp, Beth; Matar, Gassan; McDermott, Patrick; McEwen, Scott; Mitema, Eric; Reid-Smith, Richard; Scott, H. Morgan; Singh, Ruby; DeWaal, Caroline Smith; Stelling, John; Toleman, Mark; Watanabe, Haruo; Woo, Gun-Jo |
| Publisher Information: |
Oxford University Press |
| Publication Year: |
2016 |
| Collection: |
HighWire Press (Stanford University) |
| Subject Terms: |
FOOD SAFETY |
| Description: |
Antimicrobial use in food animals selects for antimicrobial resistance in bacteria, which can spread to people. Reducing use of antimicrobials—particularly those deemed to be critically important for human medicine—in food production animals continues to be an important step for preserving the benefits of these antimicrobials for people. The World Health Organization ranking of antimicrobials according to their relative importance in human medicine was recently updated. Antimicrobials considered the highest priority among the critically important antimicrobials were quinolones, third- and fourth-generation cephalosporins, macrolides and ketolides, and glycopeptides. The updated ranking allows stakeholders in the agriculture sector and regulatory agencies to focus risk management efforts on drugs used in food animals that are the most important to human medicine. In particular, the current large-scale use of fluoroquinolones, macrolides, and third-generation cephalosporins and any potential use of glycopeptides and carbapenems need to be addressed urgently. |
| Document Type: |
text |
| File Description: |
text/html |
| Language: |
English |
| Relation: |
http://cid.oxfordjournals.org/cgi/content/short/63/8/1087; http://dx.doi.org/10.1093/cid/ciw475 |
| DOI: |
10.1093/cid/ciw475 |
| Availability: |
http://cid.oxfordjournals.org/cgi/content/short/63/8/1087; https://doi.org/10.1093/cid/ciw475 |
| Rights: |
Copyright (C) 2016, Infectious Diseases Society of America |
| Accession Number: |
edsbas.7F502993 |
| Database: |
BASE |